share_log

Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARCH Venture Fund IX, L.P.(14.5%),ARCH Venture Fund IX Overage, L.P.(14.5%), etc.

Lyell Immunopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-ARCH Venture Fund IX, L.P.(14.5%),ARCH Venture Fund IX Overage, L.P.(14.5%), etc.

Lyell Immunopharma | SC 13G/A:超過5%持股股東披露文件(修正)-ARCH Venture Fund IX, L.P.(14.5%),ARCH Venture Fund IX Overage, L.P.(14.5%)等
美股sec公告 ·  02/14 15:24
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息